LEXICON PHARMACEUTICALS, INC. Unrealized Gain (Loss) on Investments
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Unrealized Gain (Loss) on Investments of -$27.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2023-05-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2023-05-04
- LEXICON PHARMACEUTICALS, INC. unrealized gain (loss) on investments for the quarter ending 2022-03-31 was -$27.00K.
- LEXICON PHARMACEUTICALS, INC. unrealized gain (loss) on investments for the quarter ending 2021-09-30 was $0.00.
- LEXICON PHARMACEUTICALS, INC. unrealized gain (loss) on investments for the quarter ending 2019-09-30 was -$50.00K, a 134.01% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. unrealized gain (loss) on investments for the quarter ending 2019-06-30 was $53.00K, a 69.89% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. unrealized gain (loss) on investments for fiscal 2018 was $210.00K.
- LEXICON PHARMACEUTICALS, INC. unrealized gain (loss) on investments for fiscal 2017 was -$27.00K, a 212.50% decline from fiscal 2016.
- LEXICON PHARMACEUTICALS, INC. unrealized gain (loss) on investments for fiscal 2016 was $24.00K.
- LEXICON PHARMACEUTICALS, INC. unrealized gain (loss) on investments for fiscal 2015 was -$156.00K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$27.00K 10-Q · filed 2023-05-04 | |||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | |||
| 2019-09-30 | -$50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $3.00K derived: sum of 2 quarters · filed 2019-11-07 | $48.00K 10-Q · filed 2019-11-07 | $107.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $98.00K 10-Q · filed 2019-08-01 | $157.00K derived: sum of 3 quarters · filed 2019-08-01 | $304.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-03-31 | $45.00K 10-Q · filed 2019-05-01 | $104.00K derived: sum of 2 quarters · filed 2019-05-01 | $251.00K derived: sum of 3 quarters · filed 2019-11-07 | $427.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $206.00K derived: sum of 2 quarters · filed 2019-11-07 | $382.00K derived: sum of 3 quarters · filed 2019-11-07 | $210.00K 10-K · filed 2019-03-15 |
| 2018-09-30 | $147.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $323.00K derived: sum of 2 quarters · filed 2019-11-07 | $151.00K 10-Q · filed 2019-11-07 | -$8.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $176.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $4.00K 10-Q · filed 2019-08-01 | -$155.00K derived: sum of 3 quarters · filed 2019-08-01 | -$4.00K derived: sum of 4 quarters · filed 2019-08-01 |
| 2018-03-31 | -$172.00K 10-Q · filed 2019-05-01 | -$331.00K derived: sum of 2 quarters · filed 2019-05-01 | -$180.00K derived: sum of 3 quarters · filed 2019-05-01 | -$130.00K derived: sum of 4 quarters · filed 2019-05-01 |
| 2017-12-31 | -$159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$8.00K derived: sum of 2 quarters · filed 2019-03-15 | $42.00K derived: sum of 3 quarters · filed 2019-03-15 | -$27.00K 10-K · filed 2019-03-15 |
| 2017-09-30 | $151.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $201.00K derived: sum of 2 quarters · filed 2018-11-01 | $132.00K 10-Q · filed 2018-11-01 | -$141.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30 | -$19.00K 10-Q · filed 2018-07-30 | -$292.00K derived: sum of 3 quarters · filed 2019-03-15 | -$550.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | -$69.00K 10-Q · filed 2018-05-03 | -$342.00K derived: sum of 2 quarters · filed 2019-03-15 | -$600.00K derived: sum of 3 quarters · filed 2019-03-15 | -$561.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | -$273.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$531.00K derived: sum of 2 quarters · filed 2019-03-15 | -$492.00K derived: sum of 3 quarters · filed 2019-03-15 | $24.00K 10-K · filed 2019-03-15 |
| 2016-09-30 | -$258.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$219.00K derived: sum of 2 quarters · filed 2017-11-08 | $297.00K 10-Q · filed 2017-11-08 | $20.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $555.00K 10-Q · filed 2017-08-01 | $278.00K derived: sum of 3 quarters · filed 2018-03-01 | $238.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $516.00K 10-Q · filed 2017-05-04 | $239.00K derived: sum of 2 quarters · filed 2018-03-01 | $199.00K derived: sum of 3 quarters · filed 2018-03-01 | $274.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | -$277.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$317.00K derived: sum of 2 quarters · filed 2018-03-01 | -$242.00K derived: sum of 3 quarters · filed 2018-03-01 | -$156.00K 10-K · filed 2018-03-01 |
| 2015-09-30 | -$40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $35.00K derived: sum of 2 quarters · filed 2016-11-07 | $121.00K 10-Q · filed 2016-11-07 | $56.00K derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | $75.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $161.00K 10-Q · filed 2016-08-04 | $96.00K derived: sum of 3 quarters · filed 2017-03-06 | $93.00K derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | $86.00K 10-Q · filed 2016-05-05 | $21.00K derived: sum of 2 quarters · filed 2017-03-06 | $18.00K derived: sum of 3 quarters · filed 2017-03-06 | $13.00K derived: sum of 4 quarters · filed 2017-03-06 |
| 2014-12-31 | -$65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | -$68.00K derived: sum of 2 quarters · filed 2017-03-06 | -$73.00K derived: sum of 3 quarters · filed 2017-03-06 | -$65.00K 10-K · filed 2017-03-06 |
| 2014-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$8.00K derived: sum of 2 quarters · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | -$36.00K derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $3.00K 10-Q · filed 2015-08-07 | -$33.00K derived: sum of 3 quarters · filed 2016-03-11 | -$26.00K derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | $8.00K 10-Q · filed 2015-05-05 | -$28.00K derived: sum of 2 quarters · filed 2016-03-11 | -$21.00K derived: sum of 3 quarters · filed 2016-03-11 | -$32.00K derived: sum of 4 quarters · filed 2016-03-11 |
| 2013-12-31 | -$36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | -$29.00K derived: sum of 2 quarters · filed 2016-03-11 | -$40.00K derived: sum of 3 quarters · filed 2016-03-11 | -$21.00K 10-K · filed 2016-03-11 |
| 2013-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$4.00K derived: sum of 2 quarters · filed 2014-11-06 | $15.00K 10-Q · filed 2014-11-06 | $17.00K derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | -$11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $8.00K 10-Q · filed 2014-08-07 | $10.00K derived: sum of 3 quarters · filed 2015-03-12 | $51.00K derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $19.00K 10-Q · filed 2014-05-08 | $21.00K derived: sum of 2 quarters · filed 2015-03-12 | $62.00K derived: sum of 3 quarters · filed 2015-03-12 | $99.00K derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $43.00K derived: sum of 2 quarters · filed 2015-03-12 | $80.00K derived: sum of 3 quarters · filed 2015-03-12 | $2.00K 10-K · filed 2015-03-12 |
| 2012-09-30 | $41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $78.00K derived: sum of 2 quarters · filed 2013-11-12 | $0.00 10-Q · filed 2013-11-12 | -$13.00K derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$41.00K 10-Q · filed 2013-08-01 | -$54.00K derived: sum of 3 quarters · filed 2014-03-07 | -$91.00K derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-03-31 | -$78.00K 10-Q · filed 2013-05-10 | -$91.00K derived: sum of 2 quarters · filed 2014-03-07 | -$128.00K derived: sum of 3 quarters · filed 2014-03-07 | -$97.00K derived: sum of 4 quarters · filed 2014-03-07 |
| 2011-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$50.00K derived: sum of 2 quarters · filed 2014-03-07 | -$19.00K derived: sum of 3 quarters · filed 2014-03-07 | $16.00K 10-K · filed 2014-03-07 |
| 2011-09-30 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$6.00K derived: sum of 2 quarters · filed 2012-11-07 | $29.00K 10-Q · filed 2012-11-07 | $35.00K derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $66.00K 10-Q · filed 2012-08-02 | $72.00K derived: sum of 3 quarters · filed 2013-03-11 | $71.00K derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-03-31 | $35.00K 10-Q · filed 2012-05-03 | $41.00K derived: sum of 2 quarters · filed 2013-03-11 | $40.00K derived: sum of 3 quarters · filed 2013-03-11 | |
| 2010-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $5.00K derived: sum of 2 quarters · filed 2013-03-11 | $5.00K 10-K · filed 2013-03-11 | |
| 2010-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-01 | -$1.00K 10-Q · filed 2011-11-01 | ||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | $0.00 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |